I don't really see any added growth as we have been averaging around 10 to 12 percent growth in income each quarter for a long time. That increase seems to be the norm, which will not get us to break even within 2 years or less. Plus, a lot of the increase in income could just be attributed to the increase in the contract price of renewals which was averaging around 38 percent. Maybe next quarter we will see a bigger increase in sales.
- Forums
- ASX - By Stock
- IPD
- Media
Media, page-257
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $107.2M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.2¢ | $68.49K | 1.292M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 14094 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.052 |
1 | 500000 | 0.051 |
5 | 190000 | 0.050 |
1 | 61000 | 0.049 |
1 | 27812 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 14094 | 1 |
0.054 | 100000 | 1 |
0.055 | 332498 | 2 |
0.056 | 250000 | 1 |
0.058 | 7842 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online